Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

An experimental levonorgestrel 20 mcg intrauterine device (LNG20 IUD) is under development by Medicines360, a San Francisco-based nonprofit pharmaceutical company.

New intrauterine device now is in research